in

A new Sickle cell disease drug holds much promise but most sufferers won’t be able to afford it (qz.com)

Novartis’ Adakveo price starts at $85,000 in the United States

Report

What do you think?

Posted by Politicl

Leave a Reply

Your email address will not be published. Required fields are marked *

The Staggering Timescales Of Nuclear Waste Disposal (www.forbes.com)

Milestone in quantum standardization (www.sciencedaily.com)